Modern Chinese Medicine Group Co., Ltd.

SEHK:1643 Stock Report

Market Cap: HK$249.0m

Modern Chinese Medicine Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Hongli Zhang

Chief executive officer

CN¥288.0k

Total compensation

CEO salary percentage100.0%
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Revenues Not Telling The Story For Modern Chinese Medicine Group Co., Ltd. (HKG:1643) After Shares Rise 32%

Nov 11
Revenues Not Telling The Story For Modern Chinese Medicine Group Co., Ltd. (HKG:1643) After Shares Rise 32%

Modern Chinese Medicine Group's (HKG:1643) Conservative Accounting Might Explain Soft Earnings

Sep 30
Modern Chinese Medicine Group's (HKG:1643) Conservative Accounting Might Explain Soft Earnings

Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock Catapults 25% Though Its Price And Business Still Lag The Market

May 22
Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock Catapults 25% Though Its Price And Business Still Lag The Market

Lacklustre Performance Is Driving Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) Low P/E

Mar 25
Lacklustre Performance Is Driving Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) Low P/E

We Think You Should Be Aware Of Some Concerning Factors In Modern Chinese Medicine Group's (HKG:1643) Earnings

Sep 02
We Think You Should Be Aware Of Some Concerning Factors In Modern Chinese Medicine Group's (HKG:1643) Earnings

Calculating The Fair Value Of Modern Chinese Medicine Group Co., Ltd. (HKG:1643)

Jun 07
Calculating The Fair Value Of Modern Chinese Medicine Group Co., Ltd. (HKG:1643)

CEO Compensation Analysis

How has Hongli Zhang's remuneration changed compared to Modern Chinese Medicine Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥14m

Mar 31 2024n/an/a

CN¥32m

Dec 31 2023CN¥288kCN¥288k

CN¥49m

Sep 30 2023n/an/a

CN¥57m

Jun 30 2023n/an/a

CN¥65m

Mar 31 2023n/an/a

CN¥77m

Dec 31 2022CN¥283kCN¥283k

CN¥88m

Sep 30 2022n/an/a

CN¥88m

Jun 30 2022n/an/a

CN¥88m

Mar 31 2022n/an/a

CN¥85m

Dec 31 2021CN¥271kCN¥271k

CN¥82m

Sep 30 2021n/an/a

CN¥74m

Jun 30 2021n/an/a

CN¥68m

Mar 31 2021n/an/a

CN¥66m

Dec 31 2020CN¥196kCN¥180k

CN¥64m

Sep 30 2020n/an/a

CN¥58m

Dec 31 2019CN¥134kCN¥103k

CN¥46m

Compensation vs Market: Hongli's total compensation ($USD39.74K) is below average for companies of similar size in the Hong Kong market ($USD232.62K).

Compensation vs Earnings: Hongli's compensation has been consistent with company performance over the past year.


CEO

Hongli Zhang (59 yo)

4.9yrs

Tenure

CN¥288,000

Compensation

Ms. Hongli Zhang is the Chief Executive Officer of Modern Chinese Medicine Group Co., Ltd. and has been its Executive Director since December 12, 2019.


Leadership Team

NamePositionTenureCompensationOwnership
Xinlei Sun
Executive Chairmanless than a yearCN¥41.00k67%
HK$ 166.8m
Hongli Zhang
CEO & Executive Directorno dataCN¥288.00kno data
Yanru Jia
Joint Company Secretary & Executive Director1.3yrsCN¥29.00kno data
Wen Tao Li
Chief Financial Officer4.8yrsno datano data
Tsz Hei Chan
Joint Company Secretary1.4yrsno datano data

1.3yrs

Average Tenure

40yo

Average Age

Experienced Management: 1643's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Xinlei Sun
Executive Chairmanless than a yearCN¥41.00k67%
HK$ 166.8m
Hongli Zhang
CEO & Executive Director4.9yrsCN¥288.00kno data
Yanru Jia
Joint Company Secretary & Executive Directorless than a yearCN¥29.00kno data
Chi Kin Wong
Independent Non-Executive Director1.6yrsCN¥77.00kno data
Tsz Wing Leung
Independent Non-Executive Director3.9yrsCN¥108.00kno data
Ling Liu
Independent Non-Executive Director3.9yrsCN¥108.00kno data

2.8yrs

Average Tenure

45.5yo

Average Age

Experienced Board: 1643's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.